EMERGENCYDRUG.COM: Keyword Density Checker

Total words: 3340 | 2-word phrases: 850 | 3-word phrases: 967 | 4-word phrases: 1011

PAGE INFO

Title	Try to keep the title under 60 characters (42 characters) Emergency Drug - Home of Generic Medicines
Description	Try to keep the meta description between 50 - 160 characters (141 characters) Emergency Drug offers newly approved generic medicines at reasonable prices. Such as Osimertinib, Palbonix, Tofacitinib, Olaparib, Ibrutinib.
Keywords	Meta keywords are not recommended anymore (141 characters) Alecensa, Alectinib, Avatrombopag, Axitinib, Baricitinib, Cabozantinib, Crizotinib, Dasatinib, Dexamethasone, Eltrombopag, Everolimus, Ibrutinib, Larotrectinib, Venetoclax, Lenvatinib, Lorlatinib, Neratinib, Niraparib, Obeticholic Acid, Olaparib, Osimertinib, Palbociclib, Palbonix, Ponatinib, Regorafenib, Venclexta, Sunitinib, Tenofovir Alafenamide, Trelagliptin, online medicine supply, medicine supply, rheumatoid arthritis icd 10, breast cancer icd 10, get meds, buy cancer medicine online, cancer medicine online, alopecia in ladies, ladies baldness, baldness in women, Alopecia in young woman, alopecia female hairstyles
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	mg – 30 tablets	5	0.49%
2	150 mgolaparib 150 mg	3	0.30%
3	– 30 tablets gen	3	0.30%
4	low blood platelet counts	3	0.30%
5	mg – 120 tablets	3	0.30%
6	150 mg – 120	3	0.30%
7	olaparib 150 mg –	3	0.30%
8	olanib 150 mgolaparib 150	3	0.30%
9	diabetes mellitus white blood	2	0.20%
10	type 2 diabetes mellitus	2	0.20%
11	capmatinib 200 mg tablet	2	0.20%
12	white blood cells cancer	2	0.20%
13	peritoneal cancer prostate cancer	2	0.20%
14	primary peritoneal cancer prostate	2	0.20%
15	cancer primary peritoneal cancer	2	0.20%
16	lung cancer primary peritoneal	2	0.20%
17	cell lung cancer primary	2	0.20%
18	mellitus white blood cells	2	0.20%
19	palbociclib 125 mg –	2	0.20%
20	blood cells cancer contact	2	0.20%
21	cells cancer contact us	2	0.20%
22	125 mg – 21	2	0.20%
23	80 mg – 30	2	0.20%
24	tabletolanib 150 mgolaparib 150	2	0.20%
25	mg tabletolanib 150 mgolaparib	2	0.20%
26	150 mg tabletolanib 150	2	0.20%
27	120 tablets gen olaparib	2	0.20%
28	– 120 tablets gen	2	0.20%
29	21 capsules gen palbociclib	2	0.20%
30	– 21 capsules gen	2	0.20%
31	mg – 21 capsules	2	0.20%
32	40 mg – 90	2	0.20%
33	mg – 90 capsules	2	0.20%
34	mgolaparib 150 mg tablet	2	0.20%
35	kidney cancer arthritis breast	2	0.20%
36	140 mg ibrutinib 140	2	0.20%
37	breast cancer breast cancer	2	0.20%
38	mg ibrutinib 140 mg	2	0.20%
39	cancers 1st stage chronic	2	0.20%
40	1st stage chronic hepatitis	2	0.20%

#	URL	Whois	Check
1	https://www.w3.org/WAI/tutorials/images/decision-tree	Whois	w3.org
2	https://www.w3.org/WAI/tutorials/images/decision-tree	Whois	w3.org
3	https://www.w3.org/WAI/tutorials/images/decision-tree	Whois	w3.org
4	https://www.w3.org/WAI/tutorials/images/decision-tree	Whois	w3.org